Intestinal parasites in cancer patients in the South of Brazil

• Main Authors: S. Jeske, T. F. Bianchi, M. Q. Moura, B. Baccega, N. B. Pinto, M. E. A. Berne, M. M. Villela
• Format: Article
• Language: English
• Published: Instituto Internacional de Ecologia 2017-11-01
• Series: Brazilian Journal of Biology
• Subjects: parasitos intestinais; pacientes imunocomprometidos; câncer
• Online Access: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1519-69842017005118105&lng=en&tlng=en

Abstract Intestinal parasitic infections in immunocompromised patients can lead to serious complications when not diagnosed and treated early. This study aimed to investigate the frequency of intestinal parasites in cancer patients undergoing chemotherapy in the South of Brazil. Three fecal samples collected from each patient (73 individuals) were processed by Ritchie and Faust techniques and submitted to specific staining methods for intestinal protozoa. A 61.6% parasite and/or commensal positivity was found. Helminths identified were Ascaris lumbricoides (33.3%), Taenia spp. (6.6%), Strongyloides stercoralis (4.4%) and Trichuris trichiura (2.2%). Among protozoans, Giardia lamblia (26.6%), Cryptosporidium spp. (13.3%) and Cystoisospora belli (4.4%) were identified. The presence of Entamoeba coli, Endolimax nana and Entamoeba hartmanni was also recorded. The results obtained warn of the importance of fecal parasitological diagnosis and the use of specific staining methods for the detection of intestinal parasites in cancer patients. These exams should be regularly requested at the patient’s first clinic visit, given the high prevalence found in this study and the possible severity of such conditions for these individuals.